Drug Type TCR-Tregs |
Synonyms HLA-A02 autoimmune program (TCR2 Therapeutics), TRuC Tregs (TCR2 Therapeutics) |
Target |
Mechanism HLA-A2 modulators(HLA-A2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft vs Host Disease | Preclinical | US | 20 Oct 2021 |